These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3713755)

  • 1. Verapamil, syncope, and hypertrophic obstructive cardiomyopathy.
    Trohman RG; Feldman T; Palomo AR; Kessler KM; Myerberg RJ
    N Engl J Med; 1986 Jun; 314(24):1583. PubMed ID: 3713755
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects of atrial fibrillation and syncope induced by calcium-channel blockers in hypertrophic cardiomyopathy.
    Doiuchi J; Hamada M; Ochi T; Ito T; Kokubu T
    Clin Cardiol; 1985 Mar; 8(3):176-9. PubMed ID: 4038927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy.
    Masini V; Ceci V; Malinconico U; Milazzotto F
    G Ital Cardiol; 1981; 11(11):1729-37. PubMed ID: 7044864
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

  • 7. Syncope induced by propranolol in hypertrophic cardiomyopathy.
    García-Rubira JC; Pavón M; Romero-Chacón D
    Int J Cardiol; 1991 Jun; 31(3):358-61. PubMed ID: 1879988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy. Combination of beta blockers and verapamil may be risky.
    Borja J; Izquierdo I; Guindo J
    BMJ; 2006 Jul; 333(7558):97. PubMed ID: 16825239
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug treatment of hypertrophic cardiomyopathy].
    Hirzel HO
    Herz; 1985 Apr; 10(2):84-90. PubMed ID: 4039293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil-induced ventricular tachycardia in hypertrophic cardiomyopathy.
    Wessel A; Seiffert P; Dettmann R; Heintzen PH
    Eur Heart J; 1987 Mar; 8(3):313-5. PubMed ID: 3582389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy.
    Perrot B; Danchin N; Terrier de la Chaise A
    Br Heart J; 1984 Mar; 51(3):352-4. PubMed ID: 6538092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
    Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
    Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
    [No Abstract]   [Full Text] [Related]  

  • 14. Verapamil in hypertrophic cardiomyopathy.
    Am J Cardiol; 1984 May; 53(10):1486-7. PubMed ID: 6539059
    [No Abstract]   [Full Text] [Related]  

  • 15. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 16. [Personal experience with the long-term administration of verapamil in hypertrophic cardiomyopathies].
    Gregor P; Widimský P; Cervenka V; Vísek V; Dvorák J; Sládková T
    Vnitr Lek; 1986 Dec; 32(12):1179-87. PubMed ID: 3824917
    [No Abstract]   [Full Text] [Related]  

  • 17. Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.
    Epstein SE; Rosing DR
    Circulation; 1981 Sep; 64(3):437-41. PubMed ID: 7196300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic occlusive cardiomyopathy.
    Kaltenbach M; Hopf R
    Clin Invest Med; 1980; 3(1-2):179-84. PubMed ID: 7008998
    [No Abstract]   [Full Text] [Related]  

  • 19. Verapamil in the treatment of hypertrophic cardiomyopathy.
    Rosing DR; Epstein SE
    Ann Intern Med; 1982 May; 96(5):670-2. PubMed ID: 6122414
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.